Cargando…

Identification of Pharmacophoric Fragments of DYRK1A Inhibitors Using Machine Learning Classification Models

Dual-specific tyrosine phosphorylation regulated kinase 1 (DYRK1A) has been regarded as a potential therapeutic target of neurodegenerative diseases, and considerable progress has been made in the discovery of DYRK1A inhibitors. Identification of pharmacophoric fragments provides valuable informatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Mengzhou, Guan, Zhen, Fan, Tengjiao, Zhang, Na, Wang, Jianhua, Sun, Guohui, Zhao, Lijiao, Zhong, Rugang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954712/ https://www.ncbi.nlm.nih.gov/pubmed/35335117 http://dx.doi.org/10.3390/molecules27061753

Ejemplares similares

Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking
por: Sun, Guohui, et al.
Publicado: (2016)

QSAR and Classification Study on Prediction of Acute Oral Toxicity of N-Nitroso Compounds
por: Fan, Tengjiao, et al.
Publicado: (2018)

Reductive Activity and Mechanism of Hypoxia- Targeted AGT Inhibitors: An Experimental and Theoretical Investigation
por: Xiao, Weinan, et al.
Publicado: (2019)

Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
por: Fan, Tengjiao, et al.
Publicado: (2019)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
por: Li, Chunqiong, et al.
Publicado: (2020)

Metabolic Activation and Carcinogenesis of Tobacco-Specific Nitrosamine N’-Nitrosonornicotine (NNN): A Density Function Theory and Molecular Docking Study
por: Fan, Tengjiao, et al.
Publicado: (2019)

Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies
por: Zhou, Yue, et al.
Publicado: (2018)

In Silico Prediction of O(6)-Methylguanine-DNA Methyltransferase Inhibitory Potency of Base Analogs with QSAR and Machine Learning Methods
por: Sun, Guohui, et al.
Publicado: (2018)

Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
por: Meine, Rosanna, et al.
Publicado: (2018)

Pharmacophoric Site Identification and Inhibitor Design for Autotaxin
por: Lee, Myeong Hwi, et al.
Publicado: (2019)

Quantitative Structure-Activity Relationship (QSAR) Studies on the Toxic Effects of Nitroaromatic Compounds (NACs): A Systematic Review
por: Huang, Tao, et al.
Publicado: (2021)

Exploring protein hotspots by optimized fragment pharmacophores
por: Bajusz, Dávid, et al.
Publicado: (2021)

Influence of the Expression Level of O(6)-Alkylguanine-DNA Alkyltransferase on the Formation of DNA Interstrand Crosslinks Induced by Chloroethylnitrosoureas in Cells: A Quantitation Using High-Performance Liquid Chromatography-Mass Spectrometry
por: Li, Lili, et al.
Publicado: (2015)

A multi-functional hypoxia/esterase dual stimulus responsive and hyaluronic acid-based nanomicelle for targeting delivery of chloroethylnitrosouea
por: Li, Duo, et al.
Publicado: (2023)

Search for the Pharmacophore of Histone Deacetylase Inhibitors Using Pharmacophore Query and Docking Study
por: Haji Agha Bozorgi, Atefeh, et al.
Publicado: (2014)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
por: Ferrins, Lori, et al.
Publicado: (2023)

The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
por: Huang, Yaxin, et al.
Publicado: (2020)

QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency
por: Sun, Guohui, et al.
Publicado: (2023)

Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies
por: Kalva, Sukesh, et al.
Publicado: (2012)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Lee, In Won, et al.
Publicado: (2017)

Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes
por: Ferrins, Lori, et al.
Publicado: (2023)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Zhang, Yi, et al.
Publicado: (2020)

Identification of Suppressors of mbk-2/DYRK by Whole-Genome Sequencing
por: Wang, Yuemeng, et al.
Publicado: (2013)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Incorporating Target-Specific Pharmacophoric Information into Deep Generative Models for Fragment Elaboration
por: Hadfield, Thomas E., et al.
Publicado: (2022)

Trio-pharmacophore DNA-encoded chemical library for simultaneous selection of fragments and linkers
por: Cui, Meiying, et al.
Publicado: (2023)

Galileo: Three-dimensional searching in large combinatorial fragment spaces on the example of pharmacophores
por: Meyenburg, Christian, et al.
Publicado: (2022)

Pharmacophore and Virtual Screening of JAK3 inhibitors
por: Rajeswari, Murugesan, et al.
Publicado: (2014)

Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques
por: Al-Balas, Qosay A., et al.
Publicado: (2013)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study
por: Galati, Salvatore, et al.
Publicado: (2022)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method
por: Yoshino, Ryunosuke, et al.
Publicado: (2015)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

A Combination of Receptor-Based Pharmacophore Modeling & QM Techniques for Identification of Human Chymase Inhibitors
por: Arooj, Mahreen, et al.
Publicado: (2013)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7pes77e8s5n1d6qdj7ngpiqkqh